Biobanking Market by Product (Consumables, Equipment & Instruments, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Storage Type, Application, End-User - Global Forecast 2024-2030

Biobanking Market by Product (Consumables, Equipment & Instruments, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Storage Type, Application, End-User - Global Forecast 2024-2030

The Biobanking Market size was estimated at USD 70.33 billion in 2023 and expected to reach USD 78.21 billion in 2024, at a CAGR 11.71% to reach USD 152.75 billion by 2030.

Biobanking involves the collection, storage, management, processing, and distribution of biological samples from humans and animals for research and clinical purposes. It serves various sectors, including pharmaceuticals, biotechnology companies, academic institutions, and healthcare organizations. Applications include drug discovery, diagnostics development, personalized medicine research, and biomarker identification. Rising chronic disease prevalence such as cancer requires early detection and treatment methodologies and necessitates efficient sample storage, increasing deployment of biobanking. Moreover, increasing focus on precision medicine and government investments in national biobank networks are propelling the growth of the market. Furthermore, ensuring sample quality control and maintaining standardized protocols in collecting, processing, and storing samples are major concerns, as inconsistencies can lead to unreliable research outcomes. Data privacy is another pressing issue, with an increasing number of biobanks handling sensitive patient information. Also, leveraging emerging technologies including robotics automation systems for sample handling, enhancing data security through digitalization using blockchain technology, and implementing environmentally sustainable practices including energy-efficient storage units create lucrative opportunities for market growth.

Regional Insights

In the Americas, the US biobanking industry plays a pivotal role in advancing biomedical research through initiatives such as the National Institutes of Health's All of Us Research Program. Furthermore, investments from state governments are driving the establishment of new biobanks. The EU biobanking market is bolstered by collaborations among various countries under initiatives such as Biobanking and BioMolecular resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC). Additionally, funding programs, including Horizon 2020, have facilitated advancements in personalized medicine. In Africa, initiatives including H3Africa have promoted the development of biorepositories across the continent to support genomics research on African populations. The APAC region is experiencing rapid growth due to government policies that allocate funds for medical innovation and precision medicine. India hosts several regional biobanks focusing on disease-specific applications such as cancer research.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Biobanking Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
• Growing private and public investments in pharmaceutical research
• Rising awareness and government initiatives in regenerative medicine

Market Restraints

• Problems associated with procedure harmonization due to decentralized nature of biobanks

Market Opportunities

• Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
• Emerging focus on biobank sustainability and development of imaging biobanks

Market Challenges

• Ethical and legal concerns associated with biobanking

Market Segmentation Analysis

• Product: Expanding software integration to facilitate the biobanking operations
• Sample Type: Increasing use of nucleic acid sample for genetic study
• Storage Type: Rising preference for automated storage systems due to its efficiency and scalability
• End-User: Expansion of biobanks in pharmaceutical sector for drug development

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biobanking Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biobanking Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

New biobanking partnership safeguards the genetic diversity of America's endangered species

Revive & Restore, in collaboration with the U.S. Fish & Wildlife Service, ViaGen Pets & Equine, U.S. Department of Agriculture, and San Diego Zoo Wildlife Alliance, has announced a groundbreaking initiative in biobanking for U.S. endangered species. This multi-institution collaboration establishes the first systematic biobanking pipeline for U.S. threatened and endangered species, safeguarding genetic diversity for present and future recovery efforts. Biobanking entails the intentional and indefinite preservation of living cells, tissues, and gametes.

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank

Crown Bioscience, a global contract research organization, has signed an agreement to acquire the IndivuServ business unit of Indivumed GmbH. This transaction includes a biobank with nearly one million samples and 60 clinical divisions across the US, Europe, and Asia, providing access to a wide range of biospecimens and blood samples. 'IndivuMed Therapeutics' continues translating high-quality biospecimens into multi-omics data, while Crown Bioscience focuses on offering biomarker development services.

CNIO biobank receives EUR 800,000 from the EU

The REACT Project, led by the National Serum Institute in Denmark (Statens Serum Institute, SSI), has received 7 million euros from the EU to research lower respiratory tract infections in biobanking. In addition to Denmark and Sweden, Spain and South Africa also participate in this initiative. The Spanish National Cancer Center (CNIO) and the Institute of Bioengineering of Catalonia (IBEC) receive almost 25% of the global budget.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biobanking Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L’AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..

Market Segmentation & Coverage

This research report categorizes the Biobanking Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
• Consumables
• Equipment & Instruments
• Services
• Software
• Sample Type
• Biological Fluids
• Blood Products
• Cell Lines
• Human Tissues
• Nucleic Acids
• Storage Type
• Automated
• Manual
• Application
• Clinical Research
• Life Science Research
• Regenerative Medicine
• End-User
• Academic & Research Institutes
• Hospitals
• Pharmaceutical & Biotechnology

Region

• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year